Our Mission
ODDIFACT is a mission-driven company (“société à mission”) committed to combining scientific innovation, patient impact, and long-term value creation.
Our mission is to enable the emergence of new treatments for rare diseases by activating underused academic research and transforming it into structured therapeutic opportunities.
As a société à mission, we pursue both financial performance and societal benefit, anchored in a long-term commitment to patients and the healthcare ecosystem.
Read our Mission Report (2024–2025)
Our Objectives
To deliver on this mission, we focus on four objectives:
1. Activate Untapped Science
Identify overlooked academic evidence and translate it into therapeutic hypotheses.
2. Build Partner-Ready Programs
Structure evidence into regulatory-ready opportunities designed for adoption and downstream development.
3. Scale Rare Disease Coverage
Apply a repeatable framework to evaluate and prioritize opportunities at meaningful scale.
4. Stay Patient-Relevant
Prioritize opportunities addressing urgent unmet needs and real-world disease burden.
Our Values
Our work is guided by principles that ensure scientific rigor and meaningful progress for rare disease patients.
1. Patient Impact
Everything begins with unmet medical needs. We focus on diseases where treatments are absent, delayed, or inaccessible.
2. Scientific Integrity
We advance only indications supported by strong mechanistic rationale, expert validation, and evidence from academic or clinical research.
3. Collaboration
Meaningful progress requires working together—from disease specialists and scientific advisors to pharmaceutical partners and manufacturing
stakeholders enabling molecule access.
4. Innovation with Purpose
We use AI to uncover opportunities within academic research and turn them into structured therapeutic programs with clear execution pathways.
5. Scalability for Global Impact
We design our approach to evaluate, validate, and advance opportunities across many different indications at scale.